Life-sciences-focused venture firm Forbion Capital Partners recently held a €360m final close for its fourth flagship fund, surpassing its initial hard-cap of €350m. Managing partner Sander Slootweg speaks to Francesca Veronesi about the fundraising process, the firm's 'build' strategy and the European life sciences venture market
Allocate, the only UK-based private equity event targeting European investors, will prepare LPs and GPs for the next economic cycle at its second annual conference.
Stella Group expects to double revenues, of which 45% would be generated outside France
Pan-European GP reportedly values the Italian ceramics business at around 10x its 2018 EBITDA
Proceeds of the Areas division sale will be used to reduce Elior's leverage ratio